Risk of Cancer-Specific Death May Remain Elevated for 30 Years
Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.
Prostate Cancer
PROSTATE CANCER ADVISOR
FEATURED CONTENT
-
-
Strategies for Managing Chronic Pain in Patients With Bone-Metastatic CRPC
An overview of prostate cancer metastases to bone is presented, including strategies for pain assessment and palliative radiotherapy. -
Prostate Cancer ADT Has Fewer Cardiovascular Risks Than Expected
Investigators found that men receiving androgen deprivation therapy for prostate cancer had a 1% rate of major adverse cardiovascular events. -
Controversy Prompts Another Update to NCCN Guidelines for Prostate Cancer
After physicians voiced concerns about an active surveillance recommendation, the NCCN panel revised the guidelines. -
Can Quality of Life Assessments Predict PFS, OS Across Cancer Types?
Recent studies showed associations between quality of life scores and survival in lung and prostate cancer as well as renal cell carcinoma.
PROSTATE CANCER NEWS
Cancer Patients With Private Insurance Pay $0 for Genetic Counseling
Cancer Patients With HIV May Not Receive Equitable Treatment
Docetaxel Does Not Improve OS, mPFS in Non-Metastatic Prostate Cancer
Radiotherapy for Prostate Cancer May Increase Risk of Second Primary Cancer
ADT May Increase Risk of Death From Cardiovascular Disease in Prostate Cancer
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Prostate Cancer
Loading... 
Loading...